Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The Regents of the University of Colorado, a body”

255 pharma patents match "The Regents of the University of Colorado, a body" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 255
Index total 30,257
Page 2 / 11

Quick answer

This filtered view shows 255 pharmaceutical patents matching "The Regents of the University of Colorado, a body" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

255 results for “The Regents of the University of Colorado, a body” · 30,257 patents in full index Clear search

  1. US 12042529

    Optimization of enzyme replacement therapy for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 23, 2024 · Expires Jul 18, 2044

    granted
  2. US 12030911

    Synthesis and biological activity of phosphoramidimidate and phosphoramidate DNA

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 9, 2024 · Expires Jul 4, 2044

    granted
  3. US 12029732

    Treatment of vascular and lymphatic disease

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 9, 2024 · Expires Jul 4, 2044

    granted
  4. US 12018081

    Photoconjugation reactions for modification of specific proteins on live cells

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  5. US 12011390

    Lacrimal drug delivery device

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 18, 2024 · Expires Jun 13, 2044

    granted
  6. US 11993638

    GM-CSF mimetics and methods of making and using same

    The Regents of the University of Colorado, a Body Corporate · Granted May 28, 2024 · Expires May 23, 2044

    granted
  7. US 11981760

    Therapeutic hydrogels and contact lens for corneal melting

    The Regents of the University of Colorado, a Body Corporate · Granted May 14, 2024 · Expires May 9, 2044

    granted
  8. US 11964985

    Anti-cancer compounds targeting Ral GTPases and methods of using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  9. US 11932867

    Methods of treating rheumatoid arthritis using RNA-guided genome editing of HLA gene

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted
  10. US 11904007

    Protection from stress, anxiety, neuroinflammation, and cognitive dysfunction

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 20, 2024 · Expires Feb 15, 2044

    granted
  11. US 11851436

    Fused bicyclic pyrimidine derivatives and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 26, 2023 · Expires Dec 21, 2043

    granted
  12. US 11806432

    Compositions, methods and uses for thermally stable multi-targeted antigens

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 7, 2023 · Expires Nov 2, 2043

    granted
  13. US 11738022

    Methods for inducing pupil dilation

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 29, 2023 · Expires Aug 24, 2043

    granted
  14. US 11679093

    2-naphthimidamides, analogues thereof, and methods of treatment using same

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted
  15. US 11602556

    Insulin mimotopes and methods of using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted
  16. US 11572588

    Methods of evaluating treatment efficacy and/or treatment duration in mycobacterial diseases

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted
  17. US 11566242

    Methods and compositions for reprogramming cells

    The Regents of the University of Colorado, a Body Corporate · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  18. US 11491111

    Thermostable vaccine compositions and methods of preparing same

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 8, 2022 · Expires Nov 3, 2042

    granted
  19. US 11472812

    Anti-cancer compounds targeting Ral GTPases and methods of using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  20. US 11466010

    Toll-like receptor 8 (TLR8) specific antagonists and methods of making and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted
  21. US 11452709

    Compositions and methods for preventing and treating radiation-induced bystander effects caused by radiation or radiotherapy

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 27, 2022 · Expires Sep 22, 2042

    granted
  22. US 11433088

    Methods for treatment of vascular endothelial dysfunction using nicotinamide mononucleotide

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted
  23. US 11433126

    Protection from stress, anxiety, neuroinflammation, and cognitive dysfunction

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted
  24. US 11376247

    Tyrosine kinase inhibitors regenerate non-cancerous tissue after cancer therapy

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted